BRISTOL, Tenn., April 11 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) will host a live webcast of its presentation discussing the
status of the Company's efforts to rebase its operations and the Company's
strategic plan for future growth. Interested persons may participate in the
webcast, which will include a slide show, on Tuesday, April 12, 2005 at 1:00
p.m. E.D.T., by visiting the website
at http://www.b2i.us/external.asp?b=1084&id=114&from=wc&L=e . A direct link
to the website can also be found on the King Pharmaceuticals home page
at http://www.kingpharm.com .
The audio portion of the webcast will also be available live by telephone.
If you choose to access the live presentation by telephone, the dial in number
is 800-374-1498 (US only) or 706-643-0395 (International).
If you are unable to participate during the live webcast, the presentation
will be archived on King's web site at http://www.kingpharm.com for not less than 30
days following the call. Additionally, a replay of the audio portion of the
webcast will be available for not less than 30 days following the live
presentation by dialing 800-642-1687 (US only) or 706-645-9291
(International), passcode 5253287#.
About King Pharmaceuticals
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
About Forward-Looking Statements
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated live webcast of the
Company's presentation. These forward-looking statements involve certain
significant risks and uncertainties, and actual results may differ materially
from the forward-looking statements. Some important factors which may cause
results to differ include dependence on King's ability to conduct its webcast
as currently planned on April 12, 2004. Other important factors that may
cause actual results to differ materially from the forward-looking statements
are discussed in the "Risk Factors" section and other sections of King's Form
10-K for the year ended December 31, 2004 which is on file with the Securities
and Exchange Commission. King does not undertake to publicly update or revise
any of its forward-looking statements even if experience or future changes
show that the indicated results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
http://www.b2i.us/external.asp?b=1084&id=114&from=wc&L=e
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, +1-423-989-8125, or David E. Robinson, Senior
Director, Corporate Affairs, +1-423-989-7045, both of King
Pharmaceuticals, Inc.
|
